Influence of plasma immunoglobulin level on antibody synthesis.

Abstract:

:In previous experimental animal studies it has been demonstrated that antibody depletion is not followed by increased antibody synthesis. To assess whether these results are conferrable to antibody-depleted humans, we measured free light chains (flcs) as markers of current antibody synthesis in 8 patients treated with immunoadsorption (IA) therapy. Specific and bulk immunoglobulin levels were obtained simultaneously. The mean serum flc concentration increased to the preapheresis value within 1 day and remained unchanged thereafter. Total immunoglobulin G (IgG) and specific antibody concentrations increased to pretreatment values in 88% and 43% of the patients, respectively, and remained below the original values in the others. In conclusion, the lack of increased flc synthesis after IA confirms the absence of a feedback mechanism regulating antibody synthesis. The restoration of serum IgG levels after IA, therefore, does not result from increased antibody synthesis but is probably related to changes of catabolism and immunoglobulin backflow.

journal_name

Blood

journal_title

Blood

authors

Goldammer A,Derfler K,Herkner K,Bradwell AR,Hörl WH,Haas M

doi

10.1182/blood-2002-01-0128

subject

Has Abstract

pub_date

2002-07-01 00:00:00

pages

353-5

issue

1

eissn

0006-4971

issn

1528-0020

journal_volume

100

pub_type

杂志文章

相关文献

BLOOD文献大全
  • How I treat elderly patients with myeloma.

    abstract::The clinical approach to older patients with myeloma has to be modified to take into account comorbidities and the likelihood of higher treatment-related toxicity. Individualization of management and adequate supportive therapy are important to obtain the best response while minimizing adverse effects. Corticosteroids...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-163329

    authors: Mehta J,Cavo M,Singhal S

    更新日期:2010-09-30 00:00:00

  • Functions of BET proteins in erythroid gene expression.

    abstract::Inhibitors of bromodomain and extraterminal motif proteins (BETs) are being evaluated for the treatment of cancer and other diseases, yet much remains to be learned about how BET proteins function during normal physiology. We used genomic and genetic approaches to examine BET function in a hematopoietic maturation sys...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-607309

    authors: Stonestrom AJ,Hsu SC,Jahn KS,Huang P,Keller CA,Giardine BM,Kadauke S,Campbell AE,Evans P,Hardison RC,Blobel GA

    更新日期:2015-04-30 00:00:00

  • Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

    abstract::Silent cerebral infarct (SCI) is the most common form of neurologic disease in children with sickle cell anemia (SCA). SCI is defined as abnormal magnetic resonance imaging (MRI) of the brain in the setting of a normal neurologic examination without a history or physical findings associated with an overt stroke. SCI o...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-02-272682

    authors: DeBaun MR,Armstrong FD,McKinstry RC,Ware RE,Vichinsky E,Kirkham FJ

    更新日期:2012-05-17 00:00:00

  • N-Glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity.

    abstract::Severe deficiency of ADAMTS13, a plasma metalloprotease, leads to thrombotic thrombocytopenic purpura. ADAMTS13 contains 10 putative N-glycosylation sites in or near its metalloprotease sequence, spacer region, thrombospondin type 1 repeat no. 4 (TSR no. 4), and CUB domains. Tunicamycin treatment markedly decreased th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-167775

    authors: Zhou W,Tsai HM

    更新日期:2009-01-22 00:00:00

  • Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.

    abstract::Bruton tyrosine kinase (Btk) has a well-defined role in B-cell development, whereas its expression in osteoclasts (OCs) further suggests a role in osteoclastogenesis. Here we investigated effects of PCI-32765, an oral and selective Btk inhibitor, on osteoclastogenesis as well as on multiple myeloma (MM) growth within ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-396853

    authors: Tai YT,Chang BY,Kong SY,Fulciniti M,Yang G,Calle Y,Hu Y,Lin J,Zhao JJ,Cagnetta A,Cea M,Sellitto MA,Zhong MY,Wang Q,Acharya C,Carrasco DR,Buggy JJ,Elias L,Treon SP,Matsui W,Richardson P,Munshi NC,Anderson KC

    更新日期:2012-08-30 00:00:00

  • Recurrent acute splenic sequestration crisis due to interacting genetic defects: hemoglobin SC disease and hereditary spherocytosis.

    abstract::A 14-year-old boy with hemoglobin SC disease and alpha-thalassemia-2 experienced five episodes of acute splenic sequestration crisis (ASSC), while two of his siblings with identical globin genotypes (SC and -alpha/alpha alpha) had no such experience. To determine if an additional red blood cell (RBC) defect was respon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Warkentin TE,Barr RD,Ali MA,Mohandas N

    更新日期:1990-01-01 00:00:00

  • Altered factor VII activity in hemophilia.

    abstract::Factor VII levels have been studied in hemophilia A and B plasmas and normal controls in a controlled, prospective study. Three assay methods were used: a standard clotting assay (FVIIc-A); a modified clotting assay (FVIIc-B) (Seligsohn et al, Blood 52:978-988, 1978); and a coupled amidolytic assay. By the FVIIc-B ass...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miller BC,Hultin MB,Jesty J

    更新日期:1985-04-01 00:00:00

  • VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

    abstract::In human follicular lymphoma the t(14; 18) chromosome translocation activates the antiapoptotic oncogene Bcl2 by linking it to the immunoglobulin heavy chain (IGH) locus. Transgenic mice expressing Bcl2 controlled by an Igh enhancer (E mu) do not develop follicular lymphoma, although they do have an increased incidenc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2469

    authors: Egle A,Harris AW,Bath ML,O'Reilly L,Cory S

    更新日期:2004-03-15 00:00:00

  • Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene.

    abstract::An animal model for malignant mastocytosis is described in mice reconstituted with bone marrow cells expressing the v-erbB oncogene. The lethal mast cell disease is characterized by massive infiltration of bone marrow, spleen, and several other visceral organs by connective tissue mast cells, which normally reside in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: von Rüden T,Kandels S,Radaszkiewicz T,Ullrich A,Wagner EF

    更新日期:1992-06-15 00:00:00

  • Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.

    abstract::We have used monoclonal antibodies (M Abs) and proteolytic fragmentation to localize structurally the functional sites of human von Willebrand factor (vWF) responsible for interaction with membrane glycoproteins GPIb, GPIIb/IIIa, and with collagen. SpII (215 kd) and SpIII (320 kd), the S aureus V-8 protease homodimeri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girma JP,Kalafatis M,Piétu G,Lavergne JM,Chopek MW,Edgington TS,Meyer D

    更新日期:1986-05-01 00:00:00

  • Serial studies in von Willebrand's disease: variability versus "variants".

    abstract::The variability of laboratory findings in von Willebrand's disease (vWd) was evaluated by performing serial studies of bleeding time (BT), factor VIII coagulant activity (VIII:C), factor-VIII-related antigen (VIIIR:Ag) and ristocetin cofactor (VIIIR:Rcof) in 50 individuals from 25 families with this disorder. The type...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Abildgaard CF,Suzuki Z,Harrison J,Jefcoat K,Zimmerman TS

    更新日期:1980-10-01 00:00:00

  • Fetal erythropoiesis following bone marrow transplantation.

    abstract::"Fetal" erythrocytes are present in older children and certain adults with hematologic disorders. To determine if regenerating bone marrow produces such cells, we examined the blood of seven allogeneic bone marrow transplant recipients. Six patients were engrafted with donor cells, while on e patients recovered autolo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alter BP,Rappeport JM,Huisman TH,Schroeder WA,Nathan DG

    更新日期:1976-12-01 00:00:00

  • Conjugation of lymphoma idiotype to CD40 antibody enhances lymphoma vaccine immunogenicity and antitumor effects in mice.

    abstract::Personalized immunotherapy of lymphoma based on tumor idiotype (Id) has shown anti-idiotype humoral immune responses in 40%-50% and cellular immune responses in 50%-75% of follicular lymphoma patients, indicating that this therapy can be clinically successful. We have developed a novel vaccine against lymphoma consist...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-355461

    authors: Carlring J,Szabo MJ,Dickinson R,De Leenheer E,Heath AW

    更新日期:2012-03-01 00:00:00

  • Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML.

    abstract::In 2017, 4 drugs received US Food and Drug Administration marketing approval for acute myeloid leukemia (AML) treatment: targeted therapies for mutant FLT3 and IDH2, a liposomal cytarabine-daunorubicin formulation for therapy-related AML and AML with myelodysplasia-related changes, and resurgence of an antibody-drug c...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-08-784066

    authors: Wei AH,Tiong IS

    更新日期:2017-12-07 00:00:00

  • Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.

    abstract::Loss or mutation of the TP53 tumor suppressor gene is not commonly observed in acute myeloid leukemia (AML), suggesting that there is an alternate route for cell transformation. We investigated the hypothesis that previously observed Bcl-2 family member overexpression suppresses wild-type p53 activity in AML. We demon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-004234

    authors: Irish JM,Anensen N,Hovland R,Skavland J,Børresen-Dale AL,Bruserud O,Nolan GP,Gjertsen BT

    更新日期:2007-03-15 00:00:00

  • Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.

    abstract::Targeted irradiation of the bone marrow with radiolabeled monoclonal antibodies (radioimmunotherapy) represents a novel therapeutic approach with both myeloablative and antileukemic potential. In an open-label, single-center pilot study, 30 pediatric and adolescent patients undergoing hematopoietic cell transplantatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-06-284349

    authors: Schulz AS,Glatting G,Hoenig M,Schuetz C,Gatz SA,Grewendorf S,Sparber-Sauer M,Muche R,Blumstein N,Kropshofer G,Suttorp M,Bunjes D,Debatin KM,Reske SN,Friedrich W

    更新日期:2011-04-28 00:00:00

  • Stromal cells retard the differentiation of CD34(+)CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic history.

    abstract::Stem cell proliferation induced by potent cytokines usually leads to a loss of primitive potential through differentiation. In this study, the ability of cytokines and murine MS5 stromal cells to independently regulate the proliferation and long-term culture-initiating cell (LTC-IC) activity of primitive CD34(+)CD38(l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.2.435

    authors: Bennaceur-Griscelli A,Pondarré C,Schiavon V,Vainchenker W,Coulombel L

    更新日期:2001-01-15 00:00:00

  • Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota.

    abstract::Bone marrow suppression is an adverse effect associated with many antibiotics, especially when administered for prolonged treatment courses. Recent advances in our understanding of steady-state hematopoiesis have allowed us to explore the effects of antibiotics on hematopoietic progenitors in detail using a murine mod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-03-708594

    authors: Josefsdottir KS,Baldridge MT,Kadmon CS,King KY

    更新日期:2017-02-09 00:00:00

  • High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.

    abstract::In lymphatic tissues, chronic lymphocytic leukemia (CLL) cells are interspersed with CD68(+) nurselike cells (NLCs), T cells, and other stromal cells that constitute the leukemia microenvironment. However, the mechanism regulating colocalization of CLL and these accessory cells are largely unknown. To dissect the mole...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-170415

    authors: Burger JA,Quiroga MP,Hartmann E,Bürkle A,Wierda WG,Keating MJ,Rosenwald A

    更新日期:2009-03-26 00:00:00

  • Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways.

    abstract::When overexpressed in primary erythroid progenitors, oncogenic Ras leads to the constitutive activation of its downstream signaling pathways, severe block of terminal erythroid differentiation, and cytokine-independent growth of primary erythroid progenitors. However, whether high-level expression of oncogenic Ras is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047050

    authors: Zhang J,Liu Y,Beard C,Tuveson DA,Jaenisch R,Jacks TE,Lodish HF

    更新日期:2007-06-15 00:00:00

  • A new chelator in the house.

    abstract::In this issue of Blood, Neufeld and colleagues present promising results on the safety and efficacy of a novel iron chelator for the treatment of transfusional iron overload. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-02-406744

    authors: Taher AT,Musallam KM

    更新日期:2012-04-05 00:00:00

  • Erythroblasts are a source of angiogenic factors.

    abstract::In adult bone marrow, mature erythroblasts are produced within structures called erythroblastic islands and then cross the endothelial barrier to reach circulation. Erythroblastic islands are composed of a central macrophage surrounded by maturing erythroblasts. In this study, it is shown that erythroid cells, but not...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.7.1968

    authors: Tordjman R,Delaire S,Plouët J,Ting S,Gaulard P,Fichelson S,Roméo PH,Lemarchandel V

    更新日期:2001-04-01 00:00:00

  • RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.

    abstract::The receptor for hyaluronic acid-mediated motility (RHAMM) is an antigen eliciting both humoral and cellular immune responses in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and multiple myeloma (MM). We initiated a phase 1 clinical trial vaccinating 10 patients with R3 (ILSLELMKL), a hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-099366

    authors: Schmitt M,Schmitt A,Rojewski MT,Chen J,Giannopoulos K,Fei F,Yu Y,Götz M,Heyduk M,Ritter G,Speiser DE,Gnjatic S,Guillaume P,Ringhoffer M,Schlenk RF,Liebisch P,Bunjes D,Shiku H,Dohner H,Greiner J

    更新日期:2008-02-01 00:00:00

  • Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter.

    abstract::Although small deletions, splice site abnormalities, missense, and nonsense mutations have been identified in patients with factor VII deficiency, there have been no reports of mutations in the factor VII promoter. We investigated a girl with factor VII levels that were less than 1% of normal in association with a sev...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Arbini AA,Pollak ES,Bayleran JK,High KA,Bauer KA

    更新日期:1997-01-01 00:00:00

  • Roles of MITF for development of mast cells in mice: effects on both precursors and tissue environments.

    abstract::The mutant tg/tg mice, which do not express mi transcription factor (MITF), lack mast cells in most tissues. Since MITF is expressed in both mast cells and tissues where mast cells develop, there is a possibility that the tg/tg mice may show abnormalities in both mast cell precursors and tissue environments. We examin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0247

    authors: Morii E,Oboki K,Ishihara K,Jippo T,Hirano T,Kitamura Y

    更新日期:2004-09-15 00:00:00

  • Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears.

    abstract::We performed a longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia and a follow-up of at least 2.5 years after diagnosis. Point mutations at codons 12, 13, and 61 of the N-ras oncogene were analyzed after in vitro amplification of N-ras specific sequences followed by do...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Kamp H,de Pijper C,Verlaan-de Vries M,Bos JL,Leeksma CH,Kerkhofs H,Willemze R,Fibbe WE,Landegent JE

    更新日期:1992-03-01 00:00:00

  • CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.

    abstract::The Hermes receptor CD44 is a multifunctional adhesion molecule that plays an essential role in the homing and invasion of neoplastic stem cells in various myeloid malignancies. Although mast cells (MCs) reportedly express CD44, little is known about the regulation and function of this receptor in neoplastic cells in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-02-833582

    authors: Mueller N,Wicklein D,Eisenwort G,Jawhar M,Berger D,Stefanzl G,Greiner G,Boehm A,Kornauth C,Muellauer L,Sehner S,Hoermann G,Sperr WR,Staber PB,Jaeger U,Zuber J,Arock M,Schumacher U,Reiter A,Valent P

    更新日期:2018-11-01 00:00:00

  • Hematopoietic stem cell transplantation for infantile osteopetrosis.

    abstract::We report the international experience in outcomes after related and unrelated hematopoietic transplantation for infantile osteopetrosis in 193 patients. Thirty-four percent of transplants used grafts from HLA-matched siblings, 13% from HLA-mismatched relatives, 12% from HLA-matched, and 41% from HLA-mismatched unrela...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-625541

    authors: Orchard PJ,Fasth AL,Le Rademacher J,He W,Boelens JJ,Horwitz EM,Al-Seraihy A,Ayas M,Bonfim CM,Boulad F,Lund T,Buchbinder DK,Kapoor N,O'Brien TA,Perez MA,Veys PA,Eapen M

    更新日期:2015-07-09 00:00:00

  • Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities.

    abstract::Over the past 2 decades considerable evidence has accumulated on the association between hepatitis C virus (HCV) and hepatitis B virus (HBV) and several hematologic malignancies, most notably B-cell non-Hodgkin lymphoma (NHL). In this review we summarize this evidence, address possible mechanisms whereby hepatitis vir...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-06-275818

    authors: Marcucci F,Mele A

    更新日期:2011-02-10 00:00:00

  • Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes.

    abstract::Alternatively activated macrophages (AAMs), triggered by interleukin-4 (IL-4) and IL-13, play a modulating role during Th2 cytokine-driven pathologies, but their molecular armament remains poorly characterized. Here, we established E-cadherin (Cdh1) as a selective marker for IL-4/IL-13-exposed mouse and human macropha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-221598

    authors: Van den Bossche J,Bogaert P,van Hengel J,Guérin CJ,Berx G,Movahedi K,Van den Bergh R,Pereira-Fernandes A,Geuns JM,Pircher H,Dorny P,Grooten J,De Baetselier P,Van Ginderachter JA

    更新日期:2009-11-19 00:00:00